“America’s IVC Defender” - McGuff Company, Inc. by Riordan Clinic
McGuff Company, Inc. was named as “America’s IVC Defender” by the Riordan Clinic. Ron Hunninghake, M.D. presented this award to Ronald M. McGuff, President of the McGuff Company, at the Riordan annual IVC Symposium in Wichita, Kansas.
This award distinguishes McGuff as an outstanding company and recognizes McGuff’s relentless pursuit of the Food and Drug Administration’s approval of Ascor® Ascorbic Acid Injection and obtain Orphan Drug status. FDA approval assures access to this important drug. This award recognizes McGuff as “America’s IVC Defender” and a leader in the education and awareness of Ascorbic Acid for Injection.
Also recognized was McGuff’s decision to make Ascor® available at an equitable price for all Complementary and Alternative Medicine (CAM) Physicians.
“All of our employees at the McGuff Family of Companies are grateful to the Riordan Clinic and especially Ron Hunninghake, M.D. for the appreciation shown us. This award is a validation of the hard work we have done to assure physicians around the country have continued access to Ascorbic Acid Injection, now and into the future.” Ronald McGuff, President of McGuff Company.
Ron McGuff (left) receiving the “America’s IVC Defender” award from Ron Hunninghake, M.D. (right) during the annual IV Vitamin C Symposium that was held in Wichita, Kansas.